JP2005516904A5 - - Google Patents

Download PDF

Info

Publication number
JP2005516904A5
JP2005516904A5 JP2003546899A JP2003546899A JP2005516904A5 JP 2005516904 A5 JP2005516904 A5 JP 2005516904A5 JP 2003546899 A JP2003546899 A JP 2003546899A JP 2003546899 A JP2003546899 A JP 2003546899A JP 2005516904 A5 JP2005516904 A5 JP 2005516904A5
Authority
JP
Japan
Prior art keywords
levonorgestrel
active ingredient
formulation
dose
additives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2003546899A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005516904A (ja
Filing date
Publication date
Priority claimed from HU0105173A external-priority patent/HU227198B1/hu
Application filed filed Critical
Publication of JP2005516904A publication Critical patent/JP2005516904A/ja
Publication of JP2005516904A5 publication Critical patent/JP2005516904A5/ja
Withdrawn legal-status Critical Current

Links

JP2003546899A 2001-11-27 2002-11-26 緊急避妊のための薬学的組成物およびその用量処方 Withdrawn JP2005516904A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0105173A HU227198B1 (en) 2001-11-27 2001-11-27 Pharmaceutical composition for emergency contraception containing levonorgestrel
PCT/HU2002/000129 WO2003045397A1 (en) 2001-11-27 2002-11-26 Dosage regimen and pharmaceutical composition for emergency contraception

Publications (2)

Publication Number Publication Date
JP2005516904A JP2005516904A (ja) 2005-06-09
JP2005516904A5 true JP2005516904A5 (https=) 2006-01-05

Family

ID=89998939

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003546899A Withdrawn JP2005516904A (ja) 2001-11-27 2002-11-26 緊急避妊のための薬学的組成物およびその用量処方

Country Status (33)

Country Link
US (1) US20050288264A2 (https=)
EP (1) EP1448207B1 (https=)
JP (1) JP2005516904A (https=)
KR (1) KR100908161B1 (https=)
CN (1) CN1551774A (https=)
AP (1) AP1849A (https=)
AT (1) ATE293978T1 (https=)
AU (1) AU2002347401A1 (https=)
BR (1) BR0210595A (https=)
CA (1) CA2450359C (https=)
DE (1) DE60203929T2 (https=)
DK (1) DK1448207T3 (https=)
EA (1) EA006545B1 (https=)
EC (1) ECSP045171A (https=)
ES (1) ES2239727T3 (https=)
GE (1) GEP20063882B (https=)
HR (1) HRP20040584B1 (https=)
HU (1) HU227198B1 (https=)
IL (1) IL159394A0 (https=)
IS (1) IS2691B (https=)
MA (1) MA27076A1 (https=)
MX (1) MXPA04005104A (https=)
NO (1) NO333984B1 (https=)
NZ (1) NZ530056A (https=)
OA (1) OA12730A (https=)
PL (1) PL206010B1 (https=)
PT (1) PT1448207E (https=)
RS (1) RS50768B (https=)
SI (1) SI1448207T1 (https=)
TN (1) TNSN04048A1 (https=)
UA (1) UA79942C2 (https=)
WO (1) WO2003045397A1 (https=)
ZA (1) ZA200404114B (https=)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007338843B2 (en) * 2006-12-20 2013-05-09 Teva Women's Health, Inc. Orally disintegrating solid dosage forms comprising progestin and methods of making and use thereof
BRPI0819571A2 (pt) * 2007-12-20 2019-09-24 Teva Womenss Health Inc "método para contracepção de emergência, pacote farmacêutico para contracepção de emergência e composição farmacêutica"
US8512745B2 (en) 2008-12-08 2013-08-20 Laboratoire Hra Pharma Ulipristal acetate tablets
CA2745541C (en) * 2008-12-12 2016-11-08 Laboratoire Hra-Pharma A method for contraception
RS55331B1 (sr) 2009-04-14 2017-03-31 Hra Pharma Lab Postupak za kontracepciju po potrebi
CN102458386B (zh) 2009-06-23 2016-04-06 拜耳知识产权有限责任公司 用于紧急避孕的药物组合物
CN101732324B (zh) * 2009-12-31 2011-12-07 广州朗圣药业有限公司 一种含有左炔诺孕酮的紧急避孕药物组合物及其制备方法
HUE029252T2 (en) 2011-06-01 2017-02-28 Estetra Sprl Process for the preparation of intermediates of estetrol
SG195121A1 (en) 2011-06-01 2013-12-30 Estetra S A Process for the production of estetrol intermediates
EP2383279A1 (en) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Process for the preparation of estetrol
HRP20170797T1 (hr) * 2011-08-11 2017-08-11 Estetra S.P.R.L. Primjena estetrola kao hitnog kontraceptiva
US9579330B2 (en) 2012-11-22 2017-02-28 Bayer Pharma Aktiengesellschaft Use and application regimen of a pharmaceutical composition containing levonorgestrel and a COX inhibitor for on-demand contraception
US9655887B2 (en) 2013-05-23 2017-05-23 Bayer Pharma Aktiengesellschaft Pharmaceutical composition and the use thereof, and application regime of said pharmaceutical composition for on-demand contraception
CN103877058A (zh) * 2014-03-26 2014-06-25 邵娜 一种左炔诺孕酮片及其制备工艺
RS61777B1 (sr) 2015-06-18 2021-06-30 Estetra Sprl Oralno-disperzibilna tableta koja sadrži estetrol
CN116077454A (zh) 2015-06-18 2023-05-09 埃斯特拉有限责任公司 含雌四醇组分的口腔分散剂量单位
HUE054589T2 (hu) 2015-06-18 2021-09-28 Estetra Sprl Szájban diszpergálódó esztetrol tartalmú tabletta
MD3310333T2 (ro) 2015-06-18 2020-06-30 Estetra Sprl Unitate de dozare orodispersabilă care conține un component estetrol
CA3178291A1 (en) 2016-08-05 2018-04-12 Estetra Srl Method for the management of dysmenorrhea and menstrual pain
DK3781171T3 (da) 2018-04-19 2022-05-02 Estetra Srl Sammensætninger og deres anvendelser til lindring af menopause-associerede symptomer
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
CN110917154A (zh) * 2019-12-12 2020-03-27 上海信谊天平药业有限公司 一种左炔诺孕酮片的制备方法
TWI893101B (zh) 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 具有降低之副作用之避孕組成物
WO2022026901A2 (en) * 2020-07-30 2022-02-03 Acer Therapeutics Inc. Nk antagonists for contraception
CN119523923A (zh) * 2024-11-21 2025-02-28 华中药业股份有限公司 一种左炔诺孕酮片及其制备方法

Similar Documents

Publication Publication Date Title
JP2005516904A5 (https=)
AP1849A (en) Dosage regimen and pharmaceutical composition for emergency contraception
KR101612197B1 (ko) 부프로피온 염산염을 함유하는 안정화된 정제 및 이의 제조방법
JP2005515966A5 (https=)
CA2661759A1 (en) Buprenophine-wafer for drug substitution therapy
HU197840B (en) Process for producing synergic pharmaceutical compositions comprising amantadin and selegilin
WO2010103544A3 (en) A novel sustained release composition of compounds selected from the class of centrally acting muscle relaxants
BR0210261A (pt) Formulações farmacêuticas para a administração eficiente de apomorfina, 6ar-(-)-n-propil-norapomorfina e seus derivados e pró-drogas destes
RU2003100507A (ru) Фармацевтические композиции
ES2383433T3 (es) Formulación farmacéutica de apomorfina para administración bucal
JP2005015479A (ja) 局所麻酔薬を含有する口中用または咽頭部用製剤
EA018589B1 (ru) Применение композиции, содержащей формотерол и дипропионат беклометазона, для предотвращения и/или лечения обострения астмы
JP2005531612A (ja) ネフォパムの製剤および痛みの治療におけるその使用
JP2021514380A5 (ja) 筋障害及び骨障害を処置するための化合物及び組成物
JPH04210924A (ja) カルシトニンの経口投与用の製薬組成物及び投薬形態
JP4752987B2 (ja) 外用剤組成物
JP2019532112A5 (ja) 結節性痒疹を治療するための抗掻痒剤
ES2241777T3 (es) Composiciones farmaceuticas que contienen terbinafina.
JP2019509309A5 (https=)
HRP20251043T1 (hr) Novi oralni farmaceutski pripravak i režim doziranja za terapiju progresivnih fibrozirajućih intersticijskih bolesti pluća
ITMI20080798A1 (it) Composizione a rilascio modificato a base di doxofillina
CN1372468A (zh) 羟乙磷酸二钠口服制剂
KR100762598B1 (ko) 항혈전성 화합물을 포함하는 구강분산성 약제 조성물
ES2872531T3 (es) Composición farmacéutica que comprende Atomoxetina y método para su preparación
JPWO2022202785A5 (https=)